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ABSTRACT
Diabetes mellitus is a complex multifactorial and heterogeneous syndrome characterized by
hyperglycemia resulting from inadequate insulin secretion or insulin action. Type one diabetes is
a chronic inflammatory disease caused by a selective destruction of the insulin-producing β-cells
in the islets of Langerhans. It is an important public health problem. It accounts for between 5%
and 10% of all diabetes cases. The main genomic region controlling the predisposition to type
one diabetes is the Human Leukocyte Antigens (HLA) class I of the major histocompatibility
complex. The aim of the present study was to evaluate HLA B-27 polymorphism and risk factor
for type one diabetic among patients visiting University of Gondar Teaching Hospital Gondar,
North West Ethiopia. Two hundred blood samples were collected from September, 2015 to
July,2016 from clinically confirmed type one diabetes mellitus patients (n= 100) and from type
one diabetes mellitussero-negative individual (n= 100) that live in the study area by studying of
case control method. HLA B-27 polymorphism was detected using PCR-SSP (single specific
primer polymerasereaction) techniques. Statistical analyses of valuable data were performed by
SPSS (version 20) package. Forty eight percent of study participant’s type one diabetes were
with in the age range of less than forty years old and 67% were male. Age (P=0.000), study
participants were living rural area (p=0.001) were associated risk factor for type one diabetes
mellitus disease at 95% CI. The allele frequency in type one diabetes patients study subject (
n=100)was 0.67 and the remaining 33.the distribution of HLA-B-27 genotype in cases (p=0.000
and control (p= 0.001) were consistence with the Hardy winberg equation. In type one diabetes
mellitus patients study subject.67of the study participantswerehomogenous for HLA B27.In
control groups the frequency of HLA-B27 was 0.25 and the remaining 75 study subjects were
negative for the mentioned allele. There was statistically significance association between HLA-
B27genotype and type one diabetes. (p=0.001, OR=1.370).
Further studies with large numbers of sample size within the same and different population are
reasonable in order to consider this polymorphism as a marker for type one diabetes mellitus
IX
.Key Words: β-cells, human leukocyte antigenB-27, gene polymorphism, type one diabetes mellitus
11.INTRODUCTION
1.1 Background
Diabetes mellitus is a complex multifactorial and heterogeneous syndrome characterized by
hyper glycaemia resulting from inadequate insulin secretion or insulin action (Njolstadet al.,
2003). It is one of leading causes of morbidity and mortality in the world, the prevalence of
diabetes around the world is increasing rapidly (WHO,2013). Estimated that diabetes resulted in
1.5 million deaths in 2012 as of 2013, 382 million people have diabetes worldwide (Shi et al.,
2014).In 2014 and 2015 the International DiabetesFederation (IDF) estimated that diabetes
resulted in 4.9 million deaths, (IDF, 2016).
The number of people with diabetes is expected to rise to 592 million by 2035. (IDF, 2014).The
highest prevalence rates are found in the North American region (9.2%), followed by the
European region (8.4%).More than 80% of diabetic deaths occur in low and middle-income
countries In Africa, the prevalence of Diabetes mellitus  is increasing and the magnitude of the
disease is progressing (Gill et al.,2009). In sub-Saharan Africa, over 12million people are
expected to have Diabetes mellitus, and 330,000 of these people will die from this disease related
complications (Motala et al., 2010).
In Ethiopia, according to World Health Organization estimation, the number of diabetics cases in
the year 2000 was 800,000 and this number is expected to increase to 1.8 million by the year2030
(Motala et al.,2010 ). There are four different types of diabetes found throughout the world type 1,
type 2, gestational diabetes, and other specific types (Shobacket al.,2011).pose the great public
health challenge.type1 diabetes mellitus is characterized by loss of the insulin producing beta cells
of the islets of Langerhans in the pancreas leading to insulin deficiency (Rotheret al.,,2007).It
accounts for between 5% and 10% of all diabetes cases (Daneman,et al.,2006).
Globally, the number of people with Diabetes mellitustype 1 is unknown although, it is estimated
that about 80,000 children develop the disease each year (Chiang, etal.2014).
2The subsequent lack of insulin leads to increased blood and urine glucose. The classical
symptoms are polyuria, polydipsia, and polyphagia and weight loss. If left untreated,
diabetes can cause many complications (WHO. 2013).Acute complications include diabetic
ketoacidosis and non ketotic hyperosmolar coma.(Kitabchi, et al., 2009)
Serious long-term complication includes cardiovascular disease, stroke, chronic kidney failure,
foot ulcers, and eyes. Several pathogenic processes ranging from autoimmune destruction of
the β-cells of pancreas to abnormalities that result in resistance to insulin are involved in the
development of diabetes. Furthermore, complications may arise from low blood sugar caused by
excessive insulin treatment complications from poorly managed type 1 diabetes mellitus may
include cardiovascular disease, diabetic neuropathy, and diabetic retinopathy, among others.
However, cardiovascular disease (Devaraj, 2006) as well as neuropathy may have an
autoimmune basis, as well. Women with type 1 diabetes mellitus have a 40% higher risk of death
as compared to men with type 1 diabetes mellitus (Huxley, 2015).
Moreover, the difference between the Epidemiologic patterns of type one diabetes mellitus by
demographic, geographic, biologic, cultural and other factors in populations are presented to gain
insight about the etiology, natural history, risks and complications of type one diabetes
mellitusdata on to one region to another could largely explain the release of the autoimmunity is
stimulated under the influence of one or more environmental factor (Kida, 1999).There is a link
between cognitive deficit and diabetes.
Similar to other autoimmune diseases, the etiology of type one diabetes millets remains obscure
but develops on a genetically susceptible background and also involves a variety of factors,
ranging from immune deregulation to environmental triggers. In addition, Genetic variants
(alleles) in the highly polymorphic human leukocyte antigen (HLA) on chromosome 6p21.3 can
lead to functional Differences in how fragments of protein are presented to  the immune system
in the early 1970s,several group investigated(Singal,1973) and found associations with type one
diabetes millets.
3HLA class I Human leukocyte antigen-B27 is a major his to compatibility complex class I
molecules that is strongly associated with ankylosing spondylitis  and related sero negative
spondyloarthritis. Ankylosing spondylitis is associated with B-27 with a relative risk of 95 which
is the highest among all HLA disease associations. The association with HLA-B27 with AS was
first reported in 1973 (Brewerton, 1973) and confirmed with related SpA later by many other
investigators.
It is currently obvious that the strongest genetic susceptibility to a predisposition is allotted to the
insulin dependent diabetes mellitus alleles located in the HLA locus of the chromosome 6p21
(Akerblom, et al.,1997). It is mainly HLA alleles that present a high risk of contracting the
disease compared to non-HLA alleles (Dorman, 1997).
41.2. STATEMENT OF THE PROBLEM
In Ethiopia, Diabetes mellitus is one of the major health problems resulted in many disability and
death. This has several consequences for the country’s economy which has impact on
achievements of sustainable growth and developments based on life cost.(WHO,2013).
The risks progression of type one diabetes has been thought to be partly accounted by multiple
genes including certain HLA genotypes and environmental factors. The genetic factors are likely
to involved several genetic alterations in immune mediated as well as molecules involved in
mechanisms of cytoadherence.
Understanding the key genetic determinants responsible for type one diabetes susceptibility is
critical to prevent frequent disease severity and for developing better therapies vaccine strategy.
For this purpose a case control molecular based study is important. As far as our knowledge goes
such types of molecular study has not been done before in the study area. So this study was
organized to fill this research gaps and to collect molecular based information.
51.3. Significance of the study
The knowledge gained since 1973, using molecular genetics approaches has produced
undisputed evidence about polymorphism associated with out immune disease like type one
diabetes disease and their complex interactions. Through human gene study different genetic
factors were found that contribute to the variability of diabetes.
Molecular analysis of candidate gene will help to determine some of the mechanisms involved
in susceptibility to type one diabetes. To understand how to combine type one diabetes
efficiently, it is necessary to know the relative importance of factor that contribute to the striking
variation among human in their experience of diabetes mellitus.
It is important that case control association studies for type one diabetes be carried out on
carefully defined sets of patients and controls to obtain scientific based information about the
factors that are related to type one diabetes pathogenesis. In type one diabetes affected areas,
putting genetic and environmental factor in to perspective will inform the design and
interpretation of intervention studies aimed at reducing the burden of type one diabetes disease
and will help rationalize research priorities. Obtaining essential data regarding the frequency of
HLA B-27 gene polymorphism and associated risk factors will help to improve the effort being
done to reduce and prevent diabetic one in the region specifically and at national level at large.
Moreover, such type of molecular analysis studies will aid in screening high risk diabetic one
patients early before the onset of the disease so as to have better treatment out comes.
6.2. OBJECTIVE
2.1. GENERAL OBJECTIV
The general objective of this study was to assess the association of HLA B-27 polymorphism and
risks of type-one diabetes milieus
2. 2.SPECIFIC OBJECTIVES
The specific objectives of this study were to:-
 Determine the frequency of HLA B-27 allele amongtype one diabetes mellitus patients in
the study area.
 Determine the proportion of HLA B27 gene polymorphism with in the study population.
 Assess the effects of HLA B27 gene polymorphism and different demographic factors on
the risk of type one diabetes mellitus
73. LITERATURE REVIEW
3.1 DIABETESMELLITUS.
Diabetes is a serious, chronic disease that occurs either when the pancreas does not produce
enough insulin, or when the body cannot effectively use the insulin it produces. Insulin, is a
hormone produced by the pancreas, controls the blood glucose level by regulating the production
and storage of glucose. In diabetes there may be a decrease in the body’s ability to respond to
insulin or a decrease in the insulin produced by the pancreas which leads to abnormalities in the
metabolism of carbohydrates, proteins and fats, resulting hyperglycemia. (Seltzer et al., 1992)
The prevalence of diabetes is higher in minority groups and among those who are socio-
economically disadvantaged, but the reason for that has not been given (Chang, et al.,
2010).There are four major classifications of diabetes mellitus, namely:-type one diabetes,
(T1D),type two diabetes,(T2D), gestational diabetes (GD),other type (type IV)
3.1.1. Type I
Type 1 diabetes mellitus (T1D) is one of the most common autoimmune diseases with several
million people already affected around the globe. It can occur at any age, but is most commonly
diagnosed from infancy to the late forties (Daneman, 2006).
It is characterized by an absolute loss of insulin secretion, and results from an autoimmune
process that destroys insulin producing ß cells within the pancreatic islet. Similar to other
autoimmune diseases, the etiology of Type one diabetes remains obscure but develops on a
genetically susceptible background and also involves a variety of factors, ranging from immune
deregulation to environmental triggers. Genetic predisposition coupled with viral agents and possibly
chemical agents. (Chiang et al., 2014)
Type one diabetic is subdivided to three categories from the etiological point of view such as
Autoimmune, Idiopathic and Double. The autoimmune group is represented by type 1A, which is
polygenic and it is the most frequent type of this disease accounting 80-90% of all type one
diabetes millets cases(Chiang et al., 2014)
8Idiopathic also called Type 1B, it has all the clinical features of type 1A, but the autoimmune
component is not detected. Double (type 1 plus type 2) diabetes has been proposed when we
have the type 1A (autoimmunity) plus type 2 (obesity, insulin resistance, dyslipidemia) diabetes
characteristics in the same individual. There has been reports in the literature that HLA (Human
Leucocytes Antigen) DR3 and DR4 loci (DR3 and DR4) are associated with high risk of T1DM
(Bluestone et al.,2010)
However, as far as our knowledge goes, there has not been any report in the literature which
describes the association of HLA-B27 polymorphism and risk of T1D in the world. Therefore,
this is the first study that attempts to see whether there will be association of HLA-B27 gene
polymorphism and risk of T1D.
3.1.2. Type II
Type two diabetes mellitus characterized by insulin resistance, which may be combined with
relatively reduced insulin secretion (Shobacket al., 2011) .The defective responsiveness of body
tissues to insulin, is believed to involve the insulin receptor. This type is the most common type
of diabetes mellitus. It is predominant forms of diabetes and accounts for at least 90% of all
causes of diabetes mellitus (Gonzalez et al., 2009).
Most patients with this form of diabetes are obese, and obesity itself causes some degree of
insulin resistance. Patients who are not obese by traditional weight criteria may have an
increased percentage of body fat distributed predominantly in the abdominal region.
Ketoacidosis seldom occurs spontaneously in this type of diabetes; when seen, it usually
association with the stress of another illness such as infection. This form of diabetes frequently
goes undiagnosed for many years because the hyperglycemia develops gradually and at earlier
stages is often not severe enough for the patient to notice any of the classic symptoms of
diabetes. Nevertheless, such patients are at increased risk of developing macro vascular and
micro vascular complications (Buehler et al., 2013).
9Whereas, patients with this form of diabetes may have insulin levels that appear normal or
elevated, the higher blood glucose levels in these diabetic patients would be expected to result in
even higher insulin values had their β-cell function been normal. It also life style factors and
genetics (Riséruset al., 2009). A number of lifestyle factors are known to be important to the
development of this disease, including obesity (body mass index of greater than 30), due to lacks
of physical activity, a lack of exercise is believed to cause 7% of cases (Lee, 2012).poor diet,
stress, and urbanization.
Dietary factors influence the risk of developing type two diabetes mellitus. Consumption of
sugar-sweetened drinks in excess is associated with an increased risk. (Malik, 2010) .The type of
fats diet is also important, with saturated fats and trans fatty acids increasing the risk and
polyunsaturated and monounsaturated fat decreasing the risk eating lots of white rice also may
increase the risk of diabetes (Hu EA, 2012).
During periods of illness or surgery, individuals who usually control their type II diabetes with
diet, exercise and oral agents, may require insulin injections. In some individuals oral agents fail
to control hyperglycemia and insulin injection is required .The complications of type II result in
disruption of lifestyle, psychosocial adjustment and health care expenses. It is frequently treated
with, self-monitoring of blood glucose and hypoglycemic agents/insulin. (Lewis et al., 1996)
3.1.3. Gestational diabetes mellitus
Gestational diabetes mellitus is commonly occurs during pregnancy, usually in the second or
third trimester, as a result of hormones secretion by the placenta, which prevents the action of
insulin. This is also resembles type II diabetes in several respects, involving a combination of
relatively inadequate insulin secretion and responsiveness. It happens about 2–10% of all
pregnancies and may improve or disappear after delivery (U.S. Department of Health and
Human Services (2014).But, after pregnancies approximately 5–10% of women with gestational
diabetes are found to have diabetes mellitus, most commonly type 2.
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Gestational diabetes is fully treatable, but requires careful medical supervision throughout the
pregnancy. Management may include dietary changes, blood glucose monitoring, and in some
cases insulin may be required (National Diabetes Statistics, 2011).However, untreated
gestational diabetes can damage the health of the fetus or mother risks to the baby include
macrodome (high birth weight), congenital cardiac and central nervous system anomalies, and
skeletal muscle malformations. Increased fetal insulin may inhibit fetal surfactant production and
cause respiratory distress syndrome. Hyperbilirubinemia may result from red blood cell
destruction. In severe cases, prenatal death may occur; most commonly as a result of poor
placental perfusion due to vascular impairment the risk factors include immediate family
members with the disease and presence of islet cell antibodies (Royleet al., 1992).
3.1.4.Other types (type IV)
This type of diabetics occurs where the disease is associated with other conditions like pancreatic
disease, hormonal disorders, and drugs such as glucocorticoids and estrogen-containing
preparations. These drugs may not, by themselves, cause diabetes but they may precipitate
diabetes in persons with insulin resistance (Panditet al., 1993).
In such cases, the classification is ambiguous, as the primacy of beta cell dysfunction or insulin
resistance is unknown. Certain toxins such as Vacor (a rat poison) and pentamidine can
permanently destroy pancreatic beta cells (Espostiet al., 1996).
Depending on the ability of the pancreas to produce insulin, the patient may require by oral
agents or insulin. Diseases associated with excessive secretion of antagonistic hormones can
cause diabetes. There are many drugs and hormones which can impair insulin action. Examples
include nicotinic acid and glucocorticoids (yajniket al., 1992).
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3.2. Causes
The cause of type 1 diabetes is unknown (WHO. 2016) a number of explanatory theories have
been put forward, and the cause may be one or more of the following: include genetic factors,
immunologic factors, environmental factors and infectious agents. (Knipet al.,2005).
3.2.1. Type I
3.2.1.1 Genetic factors
People do not inherit type I diabetes mellitus itself, but they inherit a genetic predisposition
towards developing type I diabetes mellitus. This genetic tendency has been found in people with
certain HLA. HLA is a cluster of genes that is located in the MHC Class I region on
chromosome 6, at staining region 6p21. Certain variants of this gene increase the risk for
decreased histocompatibility characteristic of type 1.responsible for transplantation of antigens
and other immune processes. The risk of developing type I diabetes is increased three to five
times in people who have one of these two HLA types (Bluestone, 2010).
3.2.1.2. Immunologic factors
People with type I diabetes have an auto-immune response, and this auto-immune response is an
abnormal response in which antibodies are directed against normal tissues of the body
responding these tissues as if they are foreign. Auto-antibodies against islet cells and against
endogenous (internal) insulin have been detected in people at the time of diagnosis and even
several years prior to the development of clinical signs of type I diabetes (Smeltzeret al.,1992).
3.2.1.3. Environmental factors
Environmental factors can influence expression of type one .It has been proposed that certain
viruses or toxins may precipitate the auto-immune process that leads to beta cell destruction, and
the events that lead to beta cell destruction are not fully understood (Knipet al.,2005).
3.2.1.4. Infectious agents
Viral infections may cause type one diabetes mellitus.Itis a virus-triggered autoimmune response
in which the immune system attacks virus-infected cells along with the beta cells in the
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pancreas.(Fairweatheret al., 2002) Several viruses have been implicated, including enter viruses
(especially coxsackievirus B), cytomegalovirus, Epstein–Barr virus, mumps virus, rubella virus
and rotavirus(Petzoldet al., 2015).
3.2.1.5. Chemicals and drugs.
Some chemicals and drugs selectively destroy pancreatic cells. Pyrinuron (Vacor), a rodenticide
introduced in the United States in 1976, selectively destroys pancreatic beta cells, resulting in
type 1 diabetes after accidental poisoning (Thayer et al., 2012).Streptozotocin (Zanosar), an
antineoplastic agent, is selectively toxic to the beta cells of the pancreatic islets. It is used in
research for inducing type 1 diabetes on rodents  (Wu et al., 2015).and for treating metastatic
cancer of the pancreatic islet cells in patients whose cancer cannot be removed by surgery
(Brentjenset al., 2001) Other pancreatic problems, including trauma, pancreatitis, or tumors
(either malignant or benign) can also lead to loss of insulin production.
3.2.2. Type II
The exact mechanisms that lead to insulin resistance and impaired insulin secretion in type II
diabetes are unknown. Genetic factors are said to play a role in the development of insulin
resistance. In addition, the following risk factors are associated with the development of type II
diabetes: age, obesity, stress, depression, family history and ethnic group (Bain et al.,2001).
Signs and symptoms present as a result of hyperglycemia (excessive sugar in the blood)there is
an increase in urine output (polyuria) which results from the glycosuria (glucose in urine)
secondary to hyperglycemia. Patients experience increased thirst (polydipsia) which is secondary
to osmotic dieresis and hyper osmolality. Increased appetite (polyphagia) results because of
cellular starvation, and decreased storage of calories.
Weight loss in the presence of polyphagia is due to the ineffective metabolism of carbohydrate,
protein and fat. Weakness and lethargy are experienced as a result of inadequate energy
production (Phipps et al., 1987). Fatigue is another symptom of diabetes mellitus. Wounds heal
poorly. They take a long time to heal due to poor blood circulation to the lower extremities.
Vaginitis may be an early complaint in females. The person may also complain of blurred vision
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(Lewis et al., 1996). Dry mucous membranes, dry skin, tachycardia and nausea may also
manifest if the patient is unable to take in enough fluids to replace the losses through osmotic
dieresis.
The signs of hypoglycemia (a deficiency of sugar in the blood) are most commonly seen as side
effects of insulin therapy or with the use of oral hypoglycemic agents in patients with diabetes
mellitus. Signs such as sweating, trembling and shakiness, which result from increased
sympathetic stimulation, cause considerable discomfort. Patients can also experience
palpitations, nervousness, hunger, faintness, weakness, irritability, headaches, visual disturbance,
marked personality changes and confusion. A coma and convulsions can follow (Phipps et al
1987).
3.3. Normal physiology
Insulin is secreted by beta cells in the islets of Langerhans in the pancreas. When a meal is eaten,
insulin secretion increases, and moves glucose from circulation into muscle, liver and fat cells.
Insulin stimulates storage of glucose in the liver and muscle; it also enhances storage of dietary
fat in adipose tissue and accelerates the transportation of amino acids derived from dietary
protein into cells. Insulin further inhibits the breakdown of stored glucose, protein and fat. In
normal conditions insulin is released continuously into the blood stream. The activity of released
insulin lowers blood glucose and facilitates a stable, normal glucose range of approximately 3.9
to 6.7 mmol/l. (McCance, et al 1997).
During fasting periods (between meals and overnight) there is a decreased release of insulin and
increased release of glucagon. Glucagon counters the effects of insulin because it stimulates the
release and breakdown of glycogen from the liver and thereby increases blood glucose levels.
The net effect of the balance between insulin and glucagon levels is to maintain a constant level
of glucose in the blood (Smeltzerandbare ,1992).
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3.4. Management and control of diabetes mellitus
The focus of the management of diabetes is maintaining a healthy lifestyle by following the
correct diet, exercising, and taking medication as prescribed.( Elliott et al., 1996).
3.4.1. Diet
Diet constitutes the foundation of diabetes management. The nutritional management of the
patient with diabetes is geared towards the following: provision of all the essential food
constituents meeting energy needs maintenance of an ideal weight decrease of elevated blood
lipid levels achievement of blood glucose levels close to normal The diet that is prescribed for
diabetic patients as well as the one that is restricted for them will be discussed. Type II diabetes
is treated by diet and exercise, and only when elevated glucose levels persist are supplements of
oral agents as well as insulin injections given (Chang, et al., 2002).
3.4. 2.1. Dietary restrictions
People with diabetes found the most difficult component of their self-care regimen to be adhering to a
healthy diet. People with diabetes were reported to be more resistant to dietary change when compared to
people with other chronic diseases (Bare et al., 1992).reported in their research study that
diabetics seem to fail in keeping to an appropriate diet for various reasons.
The patient may overeat to cope with stress and negative feelings. When the patient eats away
from home, it makes it hard for him/her to control what and how much is eaten. The patient may
not resist temptation and intense cravings. Deprived feelings, social events (Bare, 1992) also
indicate that social support is important for patients with chronic diseases as it promotes
adherence to self-care, thereby achieving better metabolic control. They further indicate that
emotional support might be a motivating factor in improving adherence to health
recommendations. (BorcJohnsen, 1984).
Diabetic patients indicated that food restriction is the main reason for failure to adhere to their
diet. The reason given is sound because people say the food is nice or well-cooked if it is salty,
fried or sweetened, but if the food is boiled or unsalted, people often say that the food is not
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palatable because they need fried, salted food, cakes and sweet drinks. Some patients have a
tendency of following a high sodium diet whereas they have been advised to follow a low
sodium diet, and others drink tea with sugar and not sweeteners. (Shehadeh,2001).
They are doing this when they think that they are not seen by health care providers, forgetting
what the end-result will be. Dietary restrictions reduce the social activities of some of the
patients, as they no longer attend parties or women's clubs, to mention but a few, for fear of
temptation. At social gatherings they eat whatever is available and in the end their blood glucose
level is not controlled and they may end up with hyperglycemia. In the case of hypertensive
patients, their blood pressure remains elevated (Bare et al., 1992).
The diet that is forbidden to diabetic patients is the one that is eaten at parties, for example,
cakes, cold drinks, sweets, fatty foods in the form of meat as well as alcoholic beverages. (Bare,
1992) indicate that alcohol ingestion needs to be completely restricted by diabetic patients
because of the danger of hypoglycemia when alcohol is taken on an empty stomach. Alcohol
consumption may lead to excessive weight gain due to the high calorie content of alcohol. The
patient on diabetes may experience headaches, warmth, nausea, vomiting, sweating and thirst
following alcohol consumption.
Excessive alcohol intake may impair a person’s ability to recognize hypoglycemia and to follow
a prescribed meal plan in order to prevent hypoglycemia. Reduction of fat intake is stressed in
order to reduce risk factors such as elevated serum cholesterol levels which are associated with
the development of coronary heart disease.
3.4. 2.2. Prescribed diet
The diet that should be followed by diabetic patients is discussed below, and reference is made to
the importance of eating three meals per day and having snacks in between meals to prevent
hypoglycemia. The diet that is recommended for diabetic patients should comprise of the
following:- Carbohydrates like brown bread, maize meal, cereals and potatoes, because they add
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bulk to the diet, making it difficult to over-eat on these foods even when eating to satisfy the
appetite. Food rich in fiber, e.g. legumes, oats, soya products, vegetables and some fruits - a high
fibre diet plays a role in lowering cholesterol in the blood, and improving blood glucose levels,
thus decreasing the need for exogenous insulin.
There are two types of fibre, soluble and insoluble. Soluble fibre lowers blood glucose and lipid
levels. It forms a gel in the gastro-intestinal tract, which slows the emptying of the stomach. The
result is a slower rate of glucose absorption from the food, and has a potentially glucose-
lowering effect. Insoluble fibre increases stool bulk and prevents constipation (Bareet al., 1992).
A low-fat diet is recommended to reduce the risk of elevated serum cholesterol levels, and
reduce weight. Vegetables can be eaten raw or boiled (without the addition of sugar, salt or
butter). Spices, herbs and salt meant for hypertensive patients, that are available at selected
supermarkets, should be used instead of ordinary salt. These reduce the accumulation of fluids in
the body caused by the intake of ordinary salt. Snacks such as fruits , proteinandvitamin should
be part of the diet and should be taken between meals to prevent hypoglycemia and to prevent
the patient from eating full meals frequently which can lead to weight gain. A glass of low fat
milk or yoghurt should be taken per day. Although they contain simple sugars, their avoidance is
inappropriate (Delportet al., 2002).
The use of a moderate amount of table sugar is gaining wider acceptance, provided the patient
can maintain adequate blood glucose levels, blood lipid levels and weight control. For some
patients, a more liberal use of simple carbohydrates can be a major factor in promoting
adherence to a meal plan .Patients should drink pure juice and diet cold drinks. Sweeteners
should be used to sweeten drinks such as tea and coffee. There are two types of sweeteners,
namely nutritive and nonnutritive sweeteners.
Nonnutritive sweeteners are calorie-free and can be taken in unlimited quantities; whereas
nutritive sweeteners should be taken in small quantities as large quantities cause hyperglycemia
indicate that diabetic patients should maintain their ideal weight.
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It is therefore important that overweight patients adhere to their diet in order to reduce weight.
They can adhere to their prescribed diet with the help of adifaxcapsules, which prevent weight
gain while the patient is following the normal diet.
This may ensure adherence to the recommended diet as the patient may eat whatever she/he
likes, at any time, but still attain the ideal body weight. Another drug said to promote and
maintain weight loss is xenical. If taken for two years, it prevents weight gain as indicated by the
report. Long-term adherence to the meal plan is one of the most challenging aspects of diabetes
management. For those who have lost weight, maintaining the weight loss is often difficult. In
order to assist these patients to incorporate new dietary habits into their lifestyles, group support
and on-going nutrition counseling is encouraged. The meal plan for all diabetic patients must
take into consideration the patient's food likes and dislikes lifestyle, usual eating times, and
ethnic and cultural background (Bare et al., 1992).
3.4. 2.3. Exercise
Exercise is considered an essential part of diabetic management. It contributes to the reduction of
weight and cholesterol level. Exercise is important because of its effect on lowering blood
glucose and reducing cardiovascular risk factors.(Peter et al., 2007) It increases the uptake of
glucose by the body muscles and improves insulin utilization. Patients should be encouraged to
exercise daily at the same time and for the same amount to maintain constant, normal blood
glucose levels. Patients need to consult the health care personnel before resuming with exercise
to give them advice on when to exercise and when not. This is important because exercising with
elevated blood glucose levels will cause increased secretion of glucagon’s, growth hormone and
catecholamine’s. The liver will then release more glucose, resulting in an increase in blood
glucose.(Peter et al., 2007).
Exercise should therefore not be performed until blood glucose levels are under 14mmol/L.
Patients should monitor blood glucose levels before, during and after exercise to determine the
effect exercise has on the blood glucose level at particular times of the day. They should be made
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aware of the possibility of exercise-induced hypoglycemia, which may occur after exercise
(Smeltzer, 1992).
Patients on insulin should take a fruit or snack before engaging in moderate exercise to prevent
hypoglycemia. The fruit or snack taken need to be deducted from the regular meal plan. The
patient may eat a snack at the end of a strenuous exercise session, and may reduce the dosage of
insulin that is peaking at the time of exercise to avoid post-exercise hypoglycemia. Exercise can
be in the form of walking, swimming, aerobics, playing soccer or participating in athletics
(Helen et al.,2004).Physical activities such as gardening and housework are also regarded as
exercise as these also assist in facilitating the effect of insulin and promote a feeling of general
well-being which reduces the stress caused by diabetes
3.4. 2.4. Treatment and Prevention of Diabetes:-
At the present time, there is no way to prevent T1D. Lifelong insulin injections are the only
available treatment for the disease. Thus, genetics does not currently play a role in the
management or prevention of T1D. Although a cure for T1D is currently unavailable, several
large multi-national investigations have been designed to evaluate a variety of primary and
secondary disease interventions (NIDDK, 2015). Insulin therapyis usually given by injection just
under the skin but can also be delivered by an pump. Some researchers believe it might be
prevented at thelatent autoimmune stage, before it starts destroying beta cells.(NIDDK. 2016).
3.4. 2.5. Immunosuppressive drugs
Cyclosporine A, an immunosuppressive agent, has apparently halted destruction of beta cells (on
the basis of reduced insulin usage), but its kidney toxicity and other side effects make it highly
inappropriate for long-term use.Anti-CD3 antibodies, including teplizumab and otelixizumab,
had suggested evidence of preserving insulin production (as evidenced by sustained C-peptide
production) in newly diagnosed type 1 diabetes patients. A probable mechanism of this effect
was believed to be preservation of regulatory T cells that suppress activation of the immune
system and thereby maintain immune system homeostasis and tolerance to self-antigens. The
duration of the effect is still unknown, however. In 2011, Phase III studies with otelixizumab and
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teplizumab both failed to show clinical efficacy, potentially due to an insufficient dosing
schedule.(Bio space. Retrieved 29 November, 2011)
An anti-CD20 antibody, rituximab, inhibits B cells and has been shown to provoke C-peptide
responses three months after diagnosis of type 1 diabetes, but long-term effects of this have not
been reported.
3.5. Human leukocyte antigen production and function
The human leukocyte antigen (HLA) system is a gene complex encoding the major
histocompatibility complex (MHC) proteins in humans. These cell-surface proteins are
responsible for the regulation of the immune system in humans. The HLA gene complex resides
on a 3 Mbp stretch within chromosome 6p21 (Beck et al.,1999). HLA genes are highly
polymorphic, which means that they have many different alleles, allowing them to fine-tune the
adaptive immune system
The HLA system is studied from various viewpoints including, organ transplantation, population
genetics, disputed parentage, disease association studies and to answer basic questions of
immune biology. Genes in this complex are categorized into three basic groups: class I, class II,
and class III. Humans have three main MHC class I genes, known as HLA-A, HLA-B, and HLA-
C. The proteins produced from these genes are present on the surface of almost all cells. On the
cell surface, these proteins are bound to protein fragments (peptides) that have been exported
from within the cell. MHC class I proteins display these peptides to the immune system. If the
immune system recognizes the peptides as foreign (such as viral or bacterial peptides), it
responds by triggering the infected cell to self-destruct (Gill et al.,2009)
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There are six main MHC class II genes in humans: HLA-DPA1, HLA-DPB1, HLA-DQA1,
HLA-DQB1, HLA-DRA, and HLA-DRB1. MHC class II genes provide instructions for making
proteins that are present almost exclusively on the surface of certain immune system cells. Like
MHC class I proteins, these proteins display peptides to the immune system.
The proteins produced from MHC class III genes have somewhat different functions; they are
involved in inflammation and other immune system activities. The functions of some MHC
genes are unknown. HLAs have other roles. They are important in disease defense. They are the
major cause of organ transplant rejections. They may protect against or fail to protect (if down-
regulated by an infection) against cancers. (Galbraith et al.,1991).
Mutations in HLA may be linked to autoimmune disease (examples: type I diabetes.) HLA genes
have many possible variations, allowing each person's immune system to react to a wide range of
foreign invaders. Some HLA genes have hundreds of identified versions (alleles), each of which
is given a particular number (such as HLA-B27). Closely related alleles are categorized together;
for example, at least 40 very similar alleles are subtypes of HLA-B27.
These subtypes are designated as HLA-B*2701 to HLA-B*2743.(Khan et al.,2010). is a class I
surface antigen encoded by the B locus in the major histocompatibility complex (MHC) on
chromosome 6 and presents antigenic peptides (derived from self and non-self antigens) to T
cells. HLA-B27 is strongly associated with ankylosing spondylitis (AS), and other associated
inflammatory diseases referred to as spondyloarthropathies.. Diseases associated with the HLA-
B27 subtype can be remembered with the mnemonic PAIR, and include Psoriasis, Ankylosing
spondylitis, Inflammatory bowel disease, and Reactive arthritis a small group (<0.5%) of people
infected with HIV are able to remain symptom-free for many years without medication. These
long-term no progresses appear to be slightly more common among people who are HLA-B27
positive(Blajchman, 1973).
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3.6. Disease associations
The relationship between HLA-B27 and many diseases has not yet been fully elucidated. Though
it is associated with a wide range of pathology, particularly seronegativespondyloarthropathy, it
does not appear to be the sole mediator in development of disease. For example, while 90% of
people with ankylosing spondylitis (AS) are HLA-B27 positive, only a fraction of people with
HLA-B27 ever develop AS. People who are HLA-B27 positive are more likely to experience
early onset AS than HLA-B27 negative individuals (Feldtkelleret al., 2003).
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4. MATERIAL AND METHODS.
4.1. Study area.
Gondar town is found in North West Ethiopia 727Km away from Addis Ababa. The town has
12°C 36’ North latitude and 37°C 28’East longitude with an elevation of 2133 meter above sea
level. Average maximum and minimum temperature is 29°C (in March and May) and 10°C (in
January and December) respectively. The mean relative humidity for an average year is recorded
at 55.7% and monthly bases it ranges from 40% In January to 79% in July (central statistics
Agency 2011).
4.2. Ethical Consideration
For this study, ethical clearance was obtained from the research and ethical committee of college
of natural and computational science, informed consent was taken from all sturdy
participants(Annex1 P-42 )
4.3. Study Design.
The study design was a case control study design
4.4. Sample Collection.
Three milliliter of one hundred blood samples were collected from clinically confirmed T1DM
patients who visited Gondar university teaching hospital from September to July, 2016using
ethylene diamante tetra acetic acid (EDTA) coated test tubes. All the samples were collected
from T1D follow up patients. In the meantime age and sex matched hundred blood samples were
collected from type one diabetes sero negative individuals (who had no T1D case or history) who
are being confirmed of having no major metabolic diseases.
The samples were transported to laboratory by using ice box and the laboratory work was done at
molecular biology laboratory of department of biotechnology from September to July, 2016.
Demographic information such as age, sex, educational status, occupation, and residence of the
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patients and controls were collected using semi structured questioner and tabulated for
associational studies and to determine the risk.
Isolation OF Genomic DNA
Genomic DNA was isolated from EDTA anti coagulated peripheral blood according to standard
proteinase K digestion and phenol chloroform extraction method (Roe et al, 1995).
Protocols:-
Frozen blood samples was thawed
↓↓
1ml of whole blood was added in 2.5 ml eppendroof. andequal volume of  0.8M 1Xsodium
citrate buffer was mixed gentlyand centrifuge 10,0000 RPM for 5 mantis  in cooling
centrifuge(4°C)
↓↓
1ml of supernatant was discarded.
↓↓
to the eppendroof 1ml of 0.8M 1Xsodium citrate bufferwas added was centrifuge 10,000 RPM
for 5 mantis  in cooling  centrifuge(4°C) for further purification .then
↓↓
375 µl of 0.2M Sodium citrate was added mix gently briefly vortexed .lt was followed by  the
addition of  250 µl 10 % of sodium dodosilsulpfhat  and 5 µl proteinase K (20mg/ml water) then
vortexad  briefly and incubated for 1 hour for 55 °C
↓↓
0 µl  mixtures of phenols(60 µl)/chloroform (57.6 µl)/ isoamyl alcohol (2.4 µl)was added to
eppendroof and  then vortexed 30 seconds then centrifuge  10,000 RPM for 5 mantis then
↓↓
The upper layer was separately transferred in a new eppindrooftube then add absolute ethanol
(00%) incubate over night for deep freeze then centrifuge 5, 0000 RPM for 5 mantis
↓↓
Then discard supernatant and add the pellet dissolved in 100 µl of tries- EDTA..
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PREPARATIONS OF AGAROSE GEL
0.5ml of (1x) TEA buffer was taken in the  beaker
↓↓
and  addAGAROSE mix gently
↓↓
(0.50gm0f agaros was added in 50  ml  of 1x TAE and then the solution was boiled (using
microwave oven)  till all gel particle was dissolved-
↓↓
-the solution was allowed to cool water bath 50°C --60°C
↓↓
Casting of the horizontal agaros  gel.
↓↓
The gel was assembled to casting tray and the comb was positioned at its
↓↓
The agaros solution was poured in to the gel tray and kept at room temperature
↓↓
The comb was carefully remove
↓↓
and the gel  replaced in electrophoresis chamber
↓↓
The chamber was filled with TAE electrophoresis buffer till it reached  3-5mm  the surface  of
over  the surface  of   the gel.
↓↓
LODING and running
↓↓
DNA (3 µl) in aggaros gel was mixed with bromophnol blue in the ratio of 3:1 and   loaded in
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the wells of the 0.8% agaros gel.
↓↓
The cathode was connected to the well side of the unit and the anode to the other side
The gel was run 60v till the bromo phenol blue tracing dye migrated near to the other end.
The quality of DNA was observed by staining the gel with ethidium bromide (0.5
µl )and visualized underUvtrancellumitantor (fig.1).
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Genomic DNA from cases group 67 male and 33 female individuals also in control groups59
male and 41 female individuals genomic DNA isolated from whole blood by phenol chloroform
method (Roe et al., 1995). The quantity and quality of the isolated DNA was analyzed by
spectrophotometer and agarose gel electrophoresis respectively before further processing.
Figure 1.Agaros gel electrophoresis of genomic DNA isolated from whole human blood M: 100bp
molecular weight marker.
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4.6. Detection of HLA B-27 antigen polymorphism.
Human leukocyte antigen B -27 gen polymorphism was detected by using PCR-
SSP (single specific primer polymerase reaction) techniques. This was done be
amplifying a 101-153 base pair (bp) of DNA fragments flanking the polymorphic
site using primer pair, HLA-27: forward CGTGGACGACACGCT-3’Reverse-
5’CTCGGTCAGTCTGTCTCGGGCCTT3’,ControlprimersequencesHGH-Forward-
5’-TGCCTTCCCAACCATTCCCTTACCATT-3’HGH Reverse 5’TCTGTTGTGTTTC-
3.’ (Sylvain, 2004) amplify the target 439 HGHPCR product. The PCR master
mix was composed of 0.65µl 100pm of each primer (euro fins)(2.5 µl of 2.75Mm
magnesium chloride, 2.5 µl of 10X PCR buffer, 1 µl of 20mM DNTP mixture and
0.2 µl 5U Tag DNA polymerase) (soils bio dye),16.5 µl sterilized double distilled
water and 1 µl template DNA for 25 µl reaction Volume. PCR condition utilized
to amplify the gene of interest was optimized as follows: initial denaturation at
94°C for 5minutes, followed by; 94°C as denaturation temperature for one
minute, 65°C as annealing temperature for two minute and 72°C as an
extension temperature one minute; for 35 cycles of amplification .The final
extension temperature was 72 °C for 10°C minute. After PCR amplification the
product was run in 1.5% of agrose gel and it was observed by gel
documentation system.
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4.7. Data Analysis
Statistical Analysis was performed with the SPSS (version, 20) package. Data like age, sex,
residence, educational status, occupation were analyzed for possible associated risk factor. The
risk of type I diabetics and HLA-B 27 gene association was computed using chi- square test and
odds ratio with confidence interval (CI 95%) which are interpreted as the relative risks of disease
for T1DM. Allele frequencies were calculated by genotype counting, deviation from Hardy-
Weinberg equilibrium was tested using a chi- square with one degree of freedom. Probability
(P)< 0.05 was taken as the level of significance.
29
5. RESULTS
5.1. Demographics of study participant type one patients and control.
The demographic distribution of type one diabetes patients (n=100) and T1D sero-negative
control participants (n=100) is present in Table one. Among the study patients the highest
incidence of the disease was found among the age group < 40 years old which covers 48% of the
study participants and the list affected age groups were greater than 75 years old. Among the100
type I diabetics patient 67 (67%) were male and the remaining were female. With respect to
educational status and occupation the most affected patient groups were illiterate (43%) and
unemployed (70 %), respectively. Around 75% of the type one diabetes patients came from rural
keelson the other hand 56% of the control groups were in the age range of < 40 years old. With
respect to sex 59% of the control groupware male, from educational points of view 39% of the
controls were illiterate, when occupational status of the control group was tabulated 73% of were
unemployed 27% were employed.
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Table1: Demographic characters of study participants
_____________________________________________________________________________________________
Character type one diabetes patients type one diabetes sero- negative
Case-groups   (n=100)                 control groups(n=100)  percent
_____________________________________________________________________________________________
Risk factors Frequency percent Frequency percent
_______________________________________________________________________________  _______
Age ≤ 40                   48 48 56 5
40-75 45                                45 35 35
≥ 75                              7                                 7     9            9
Sex
Male 67 67 59 59
Female 33 33    41        41
_______________________________________________________________________________________________
Residence
Urban 25                             25 31   31
Rural 75 75  69      69
.________________________________________________________________________________________________
Educati.st   Illiterate 43 43 39       39
0-4                               18 18    21         21
5-8                                  34 34 30 30
≥ 9 5                                 5 10 10
___________________________________________________________________________________________
Occupation Employed.                30                        30        27 27
un employed.            70 70 73     73.
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5.2. The Association of demographic characters (risk factors) and type one diabetes disease.
Different risk factors (age, sex, residence, educational status, and occupation)were considered
and analyzed for their risk factor for type one diabetes. Based on the result of the study age and
residence has statistically significance risk associated with type one diabetic mellitus. As shown
in Table 2 age group 40 years old (OR 1.370, P=0.0012) and 41-75 years old( OR=1.85,
,P=0.0031) were likely affected by type one diabetes in compassion with age group greater than
75 years old. The risks analysis also showed residence living in rural was at a higher risk for type
one diabetes infection than rural.(OR=3.14.P=0.001).
Based on the result of this study sex (p=0.119) and educational states (0.0554) and occupation(
p=0.0811).were not statistically associated to risk of type one diabetes militates disease in the
study subjects (cases).
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Table 2: Binary logistic regression analysis of risk factors for of T1D in the study participants
___________________  _________________________________________________________________
Risk Factors P-value O.R
_________________________________________________________________________________
0.000
Age. ≤ 40 .269 .41 1.370
40-75           .315 0.00 1.85
___________________________________________________________________________________
Sex.
Female          369           .119                         1.92
__________________________________________________________________________________
Educati.st
Illterate. 874 .499 .190
0-4                   .83.918   1.086
5-8                     .214 ..691 1.23
_____________________________________________________________________________________
Residence
Rurul. 1.145       .001                     3.14
_____________________________________________________________________________________
Occupation.
Employed         .854                  .297                             .426
_____________________________________________________________________________________
=Beta value
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5.3. The Association of HLAB-27.allele and demographic parameters
The association of HLA-B27 allele and demographic parameters is given in Table 3 below. It was
found that some of the demographic characteristics such as rural residence is found to have
significance risk factor for the development of T1D patients the ( p value 0.001). T1D patients
that live in rural site were 68% more likely to development T1D as compared to urban residence
(0R=3.15). Other factors such as sex, occupation and marital status did not show statistically
significance association in developing T1D (p value 0 .369,0.297, 0.424), respectively.
The  results of this study showed that, age and resedence have strongly assocation beteween
HLA B-27 geno trype  and risks ofor type one diabetes disease development (p=
0.00.,..0.001),respectily. Howevet,sex, educational status ,and occupation did not show
nosignificance associatin beteweenHLA B-27 geno trype  and risks of for type one diabetes
disease development (P=0.101,.357 and ,.811).
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Table 3. Frequency of HLA B-27gene among study subjects (Note: P value; DF and x2 test were
computedbySPSSversion8.(DF degree of freedom,*p<0.05)
____________________________________________________________________________________________
Type one diabetes case      control groups
Risk Factor           present    absent     present absent                                 DF X2 test p-value
HLA B27% HLA B27%      HLA B-27% HLA B-27
__________________________________________________________________________________________
Age.
≤ 40 37 (77.08%)     11 (22.91%)     15 (73.77%)     46(26.2%) 3                   .000
40-75                 26 (57.77%)     19(42.22%)      7 (62.5%)         22(37.5%)
≥ 75 4(57.14%)          3(42%)             3(50%)            7(50%)
____________________________________________________________________________________________
Sex.
Male. 41 (59.4%)      23 ( (33.33%)     38(54.2%)      32(45.7)                     1                      .101
Female               .28 (77.77%)    8( 25.80%)        12 (40%)       18(60%)
____________________________________________________ _________________________________________
Educational status
Illiterate 31(72.02) 12(27.90%)        7( 35%) 13 ( 65%)
0-4                     22 (64.7%)      12(35.29)         11(36 .6%)     19(63.33)3 .357
5-8 13 72,22%) 5(27.777%).     6(30% 14 (70%)
≥  9                      3(60%)           2 (40%) 17(55,6)       13(54.4%)
__________________________________________________________________________________________
Residence
Urban                 11(37.93%)     18(62%)             17(37.7%)     28 (62.3 %)                    1                    .001
Rural                  57 ( 80.5  %)    14(19.71%)        19(34.5%)      36 (63.5%)
Occupants.
Unempl. 51(72.8%)      19(27.14%)         23(45%)           27 (56%)
35
Employed           21(70%)           9(30%)                19(38%)         31 (62%) 1 .811
Figure 2. Representative agarose gel PCR amplification ofHLA-B27gene,  Lane M=100bp
DNA marker, Lanes 1,2,7 149bp. HLA B-27 mutant gene, lanes 3,4,5,6,8 are negative for
HLA-B27
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5.4. The frequency ofHLAB-27gene in Type one diabetes patients
After amplification a sharp band of 149 bps of amplified DNA was visualized under UV lights.
Out of one hundred cases68 study subjects were positive and the remaining 32 cases were
negative for HLA-B27 mutant allele. On the other hand, out of 100 control groups 75 individuals
were negative and the remaining 25 individuals were positive for HLA-B27 mutant allele. There
was statistically significance association between HLA-B27 polymorphism ad risk of T1DM
among cases (p=0.001, OR=3.14).
Table 4.The frequency of HLA B-27genotypes and allele in frequency in cases and controls of Type
one diabetes patients
______________________________________________________________________________
Study group Genotype frequency (genotypes) allele frequency    p-value
Numbers of individuals
Cases           67%..67 .ooo
______________________________________________________________________________
Controls 25%                       .25. . 001
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6. DISCUSSION
Several study with different population in the world described the presence of genetic alteration
in the HLA gene. Indifferent population effects of these gene mutants were contradictory.
Difference in susceptibility to type one diabetes due to population diversity based on SNPs
(Single Nucleotide polymorphisms) in HLA gene may be result of divers evolutionary pressure
between ethnicity as well as types of HLA and incidence of several forms of disease(Broninget
al.,1996) and (Hakonarsonet al.,2011). Type 1 diabetes is a polygenic disease which results from
the interaction between environmental (viral, toxic, nutritional, socioeconomic (Dormant
et.al.,1997) and genetic factors. It is the form of diabetes which occurs mainly in children and
young adults (Bach,1989).Fortunately, molecular epidemiology offers the hope of the possibility
of preventing the disease in the future, by evaluating the potential factors of risk of developing
this pathology.
Besides, geographical location environmental condition and different socio demographic
characteristics genetic behaviors of individuals have roles for diabetes mellitus disease and verity
(Dfahlquistetallet al.,1998) .It is well established that associations between type 1 diabetes and
certain HLA antigens largely facilitate the identification of the subjects having a potential risk to
develop the disease.
According to the result of the present study all age groups and both sexes affected by type one
diabetes mellitus disease. From the total type one diabetes mellitus patients 48 % were within the
age range of ≤ 40 year old and 45%were from 41-75 years old. As compared to the females,
males were highly affected by type one diabetes mellitus disease (67%) were females although
there was no statistically significance difference between them(p = .119). This result was
consistent with health care in Ethiopia. which is carried out in area reputed the existence diabetes
mellitus in all age group and both sex with high incidence in male 18.32 year old age group ,
similarly in a study that was carried out in the same place the prevalence of type one diabetes
was higher in 30.4 year old .( Ayesha et al., 2003).
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Association between different demographic variation and type one diabetes disease were
analyzing by binary logistic regression and the result is summarized in Table 3. The result of this
study indicated that residence that is living in rural areas has shown relative increased risk for
type one diabetes disease. Age < 40 years (OR = 3.14, p=0.001) was found to be a risk factor
for diabetes mellitus disease as compared the age > 40 years old. This result is in consistent with
another study doneSaudi which also have shown that age ,40 is a risk factor for diabetic militias
one (Brown, 1998 ). The present study of HLA –B27 polymorphism was determined through
PCR-SSP techniques by using specific primer and control of human growth hormone. In this
study among the 100 type one diabetes mellitus sero positive study subjects67 individual (67%)
waspositive for HLA-B27 mutant gene.
Therefore, there was statistically significance association between type one diabetes Miletus (P =
0.001) and HLA-B 27 mutant gene. HLA- B-27 is MHC class one molecule that is strongly
associated with different type of diseases such as Ankylosing spondylitis and related
spondyloarthritis. There is almost 90% association of HLA-B27 with ankylosing spondylitis
(Michael et al.2005).
Moreover, this gene polymorphism has been associated with risk of other diseases such as
Psoriasis, Ankylosing spondylitis, Inflammatory bowel seas, and reactive arthritis(Mitchell et al.,
2007).
The relationship between HLA-B27 and many diseases has not yet been fully elucidated. Even if
HLA-B27 gene polymorphism has been associated in increasing many different type of disease,
there is no any information in the literature that has been discussion the association of this gene
with type one diabetics. As a result this makes difficult in discussing and comparing this finding
with other similar studies.
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7. CONCLUSION
In the present study, it is indicated that HLA- B27 mutant allele has increased the risk of
developing type one diabetic among study subjects. Moreover, there exist strong associated
between the frequency of HLA B-27gene polymorphism age and inhabitancy towards increasing
the risk of diabetic one among study subjects. However, it is early to call for the use of this allele
as a marker for the risk of type one diabetic mellitus due to small sample size and inadequate
data for comparison with other studies with similar and different genetic back grounds.
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8. RECOMMENDATION
To have better treatment out comes molecular and genetic testing is vital and crucial. Therefore,
engaging with similar type of study for diabetic and other metabolic disease that did not have
great attention like communicable disease is an important instrument to reduce the number of
working population that have acquired such metabolic diseases. To further use and recommend
this gene polymorphism as a marker for early diagnosing of type one diabetic mellitus similar
study with large sample size and different or similar study design is warranted. From the
presentstudy it could be recommended that early diagnosis and intervention towards this disease,
similar molecular studies on other metabolic genes is essential.
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Appendix
Annex   1
University of Gondar
College of Natural and Computational Sciences
Department of Biotechnology
The English version of the Consent Form
Title  of  The research Association of Human leukocyte antigen (HLA) B-27 polymorphism and risk
of diabetic type 1 among patients visiting Gondar University teaching hospital
1. The undersigned--------------------------Who is living at --------------zone--------wereda--------kebele
and-------Town Willingly, agree to provide 3 ml of my blood sample for the principal investigator
of this research .the investigators should ethically bind and use this blood sample only for the
said research and will completely be responsible  if you don’t keep the result and states of
the sample confidential.
Name and signature of the participant
Date.
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---------------------------------------------- ---------------.
Annex 2 The Amharic version of the Consent Form)
ጎንደርዩኒቨርስቲ
የተፈጥሮናቀመርሳይንስኮሊጅ
የባዮተክኖሎጅት/ክፍል
የምርምሩርዐስ፡The research Association of Human leukocyte antigen (HLA) B-27 polymorphism and risk
of diabetic type one among patients visiting Gondar University teaching hospital
እኔ_________________ የተባልኩትግለስብ በ-----------------ዞንበ--------------
ወረዳበ--------ቀበሌእናበ ----------ከተማየምኖር
መስሆን፤3
ሚሊየሚሆንደማንለናሙናለመስጠትስስማማ፤የሰጠሁትደምከተባለዉአገልግሎትዉጭእንደማይዉ
ልናከተባለዉዉጭ
ለሚሰሩስራዎችምርምሩንየሚያካፈሉሰወችሀላፊነትእነደሚወስዱበመተማመንነዉ፡፡
49
የተሳታፊዉስምናፊርማቀን
---------------------------------
Annex 3
University of Gondar
College of Natural and Computational Sciences
Department of Biotechnology
Title  ofThe research Association of Human leukocyte antigen (HLA) B-27 polymorphism and risk
of diabetic type 1 among patients visiting Gondar University teaching hospital
Questionnaire to be filled by physician/nurse/laboratory technician by interviewing the
patien
Names of hospital health center____________________________________sample no.
____________
Age_________________ sex____________
Locality_________________________________________________________
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Educationnal Status. ____________________
Marital status,______________________________________________
Occupation._____________________________
Name and signature of the physician/nurse/laboratory
technicion_________________________________.
________________________________________________________________________________________________________ ________________________________________
